Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/14/21
End: 07/14/25
Due: 07/14/26
Phase: N/A
Priority: Normal
Start: 10/11/19
End: 03/19/20
Due: 03/19/21
Phase: N/A
Priority: Normal
Start: 05/14/15
End: 09/02/15
Due: 09/02/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy | NCT05052398 | Algenis SpA | user2@example.com | None | 2021-01-14 | 2025-07-14 | 2026-07-14 | - | - | 2025-07-14 |
| Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study | NCT04799041 | Algenis SpA | user2@example.com | None | 2019-10-11 | 2020-03-19 | 2021-03-19 | - | - | 2025-07-14 |
| NAVX-010-Phase I Tolerability and Pharmacokinetic Study in Healthy Male Subjects | NCT03655522 | Algenis SpA | user2@example.com | None | 2015-05-14 | 2015-09-02 | 2016-09-02 | - | - | 2025-07-14 |